<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McLeod D</submitter><funding>Division of Emerging Frontiers</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>Division of Chemical, Bioengineering, Environmental, and Transport Systems</funding><pagination>26</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12614770</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(3)</volume><pubmed_abstract>Biofilm infections represent a major public health threat due to their high tolerance to antimicrobials and the lack of specific anti-biofilm drugs. To develop such drugs, it is crucial to have high-throughput biofilm growth systems that can emulate in vivo conditions without the cost and complexity of animal models. However, no current biofilm reactor can provide in vivo-like conditions in a high throughput standard microtiter format. This paper demonstrates a novel high-throughput (HT) microfluidic perfusion biofilm reactor (HT-μPBR) compatible with a standard 96-well microtiter plate for in situ optical analysis. A snap-on liquid-tight cover for standard microtiter plates was designed and fabricated with fluidic channels to provide closed-loop recirculating perfusion. Our system takes s</pubmed_abstract><journal>Biomedical microdevices</journal><pubmed_title>A standard 96-well based high throughput microfluidic perfusion biofilm reactor for in situ optical analysis.</pubmed_title><pmcid>PMC12614770</pmcid><funding_grant_id>1830941</funding_grant_id><funding_grant_id>R01 HL144157</funding_grant_id><funding_grant_id>R01HL144157</funding_grant_id><funding_grant_id>1743662</funding_grant_id><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>McLeod D</pubmed_authors><pubmed_authors>Wei L</pubmed_authors></additional><is_claimable>false</is_claimable><name>A standard 96-well based high throughput microfluidic perfusion biofilm reactor for in situ optical analysis.</name><description>Biofilm infections represent a major public health threat due to their high tolerance to antimicrobials and the lack of specific anti-biofilm drugs. To develop such drugs, it is crucial to have high-throughput biofilm growth systems that can emulate in vivo conditions without the cost and complexity of animal models. However, no current biofilm reactor can provide in vivo-like conditions in a high throughput standard microtiter format. This paper demonstrates a novel high-throughput (HT) microfluidic perfusion biofilm reactor (HT-μPBR) compatible with a standard 96-well microtiter plate for in situ optical analysis. A snap-on liquid-tight cover for standard microtiter plates was designed and fabricated with fluidic channels to provide closed-loop recirculating perfusion. Our system takes s</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jul</publication><modification>2026-05-16T03:18:00.56Z</modification><creation>2026-05-16T03:12:57.478Z</creation></dates><accession>S-EPMC12614770</accession><cross_references><pubmed>37493818</pubmed><doi>10.1007/s10544-023-00668-w</doi></cross_references></HashMap>